FDA Finalizes Guidance on Drug/Device Combination Product Classifications

Drug Industry Daily
The FDA finalized guidance on its process for assigning applications to a specific regulatory center, hoping to answer frequently asked questions from industry sponsors regarding whether their product will be classified as a drug or as a device.

To View This Article:


Subscribe To Drug Industry Daily